MC3 점액표피양 암종세포에서 비타민 K2의 항암효과
페이지 정보

본문
Vitamin K (VK) is a fat-soluble vitamin and is known to have anticancer activity in various cancer cell lines. However, there is no report on the anticancer effect of VK2 in mucoepidermoid carcinoma cells. The effects of VK2 on anti-proliferative and apoptotic activity were recognized by the trypan blue exclusion assay, 4'-6-diamidino-2-phenylindole (DAPI) staining and Western blot analysis. The results showed that VK2 decreased cell viability and induced apoptotic programmed cell death in MC3 cells evidenced by the cleavages of caspase3 and PARP. VK2 treatment clearly increased Bak and truncated Bid (t-Bid) compared with
the control treatment whereas it did not alter other Bcl-2 family members. Overall, our results suggest that VK2 can be a good apoptotic inducer accompanied by the increase in Bak and Bid protein. VK2 may be a potent target of anticancer drug candidate for the treatment of oral cancer.
the control treatment whereas it did not alter other Bcl-2 family members. Overall, our results suggest that VK2 can be a good apoptotic inducer accompanied by the increase in Bak and Bid protein. VK2 may be a potent target of anticancer drug candidate for the treatment of oral cancer.
첨부파일
-
201705127E6DE9.pdf (0byte)
65회 다운로드 | DATE : 2020-02-25 00:00:00
- 이전글타액선에 발생한 점액표피양암종, 선양낭성암종과 다형성선종간의 lysyl oxidase 발현 차이 20.02.25
- 다음글구강편평세포암종에서 TIMP-1과 TIMP-2의 발현과 조직학적 침습양상과 분화도와의 상관관계 20.02.25
댓글목록
등록된 댓글이 없습니다.